ATE229340T1 - Relaxinartiger faktor und damit zusammenhängende verfahren und verwendungen - Google Patents
Relaxinartiger faktor und damit zusammenhängende verfahren und verwendungenInfo
- Publication number
- ATE229340T1 ATE229340T1 AT96920364T AT96920364T ATE229340T1 AT E229340 T1 ATE229340 T1 AT E229340T1 AT 96920364 T AT96920364 T AT 96920364T AT 96920364 T AT96920364 T AT 96920364T AT E229340 T1 ATE229340 T1 AT E229340T1
- Authority
- AT
- Austria
- Prior art keywords
- related methods
- relaxing factor
- factor
- relaxin
- analogs
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/64—Relaxins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/484,219 US5911997A (en) | 1995-06-07 | 1995-06-07 | Relaxin-like factor and methods and uses thereof |
PCT/US1996/007399 WO1996040186A1 (en) | 1995-06-07 | 1996-05-16 | Relaxin-like factor and methods and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE229340T1 true ATE229340T1 (de) | 2002-12-15 |
Family
ID=23923245
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT96920364T ATE229340T1 (de) | 1995-06-07 | 1996-05-16 | Relaxinartiger faktor und damit zusammenhängende verfahren und verwendungen |
Country Status (9)
Country | Link |
---|---|
US (2) | US5911997A (de) |
EP (1) | EP0831871B1 (de) |
JP (1) | JP3830520B2 (de) |
AT (1) | ATE229340T1 (de) |
AU (1) | AU709115B2 (de) |
CA (1) | CA2224080C (de) |
DE (1) | DE69625354T2 (de) |
ES (1) | ES2188763T3 (de) |
WO (1) | WO1996040186A1 (de) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69624925T2 (de) * | 1995-08-15 | 2003-09-04 | Connetics Corp | Verwendung von relaxin zur stimulierung der angiogenese |
DE19641378C1 (de) * | 1996-09-27 | 1998-04-02 | Ihf Inst Fuer Hormon Und Fortp | Diagnosehilfe sowie Verfahren zum Nachweis der Trächtigkeit von Wiederkäuern |
GB9717652D0 (en) * | 1997-08-20 | 1997-10-22 | Nycomed Imaging As | Method |
AUPR814401A0 (en) | 2001-10-08 | 2001-11-01 | Howard Florey Institute Of Experimental Physiology And Medicine | Human 3 relaxin |
US20050186526A1 (en) * | 2002-11-01 | 2005-08-25 | Bas Medical, Inc. | Methods and systems for enabling and stabilizing tooth movement |
AU2003903124A0 (en) * | 2003-06-20 | 2003-07-10 | Mark Del Borgo | Analogues of heteromeric proteins |
US7878978B2 (en) * | 2004-03-18 | 2011-02-01 | University Of Pittsburgh- Of The Commonwealth System Of Higher Education | Use of relaxin to increase arterial compliance |
US7553813B2 (en) * | 2004-04-30 | 2009-06-30 | Corthera, Inc. | Methods and compositions for control of fetal growth via modulation of relaxin |
US20060052304A1 (en) * | 2004-09-02 | 2006-03-09 | Bas Medical, Inc. | Method for remodeling bone and related sutures |
EP1984016A1 (de) * | 2006-02-17 | 2008-10-29 | Associazione Foresta Per La Ricerca Nella Riproduzione Umana | Verwendung von insulin-artigem faktor 3 zur behandlung von osteoporose und knochenerkrankungen |
CA2742792A1 (en) * | 2008-11-24 | 2010-05-27 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Prediction and prevention of preeclampsia |
BR112013003522B1 (pt) | 2010-08-17 | 2021-05-25 | Ambrx, Inc. | polipeptídeos relaxina modificados compreendendo um aminoácido não codificado naturalmente, seu método de preparação e seu uso, bem como ácido nucleico e célula hospedeira |
US9567386B2 (en) | 2010-08-17 | 2017-02-14 | Ambrx, Inc. | Therapeutic uses of modified relaxin polypeptides |
BR112014002124A2 (pt) * | 2011-08-04 | 2017-02-21 | Pharis Biotec Gmbh | processo para preparar relaxina-2 humana |
WO2013177529A1 (en) * | 2012-05-24 | 2013-11-28 | Angion Biomedica Corp. | Relaxin-like compounds and uses thereof |
US9393288B2 (en) | 2012-05-29 | 2016-07-19 | The University Of Vermont And State Agricultural College | Methods of treating diseases associated with PPARγ |
US20160060322A1 (en) * | 2012-09-10 | 2016-03-03 | Angion Biomedica Corp. | Relaxin-like peptides and uses thereof |
JP6822839B2 (ja) | 2013-09-13 | 2021-01-27 | ザ・スクリップス・リサーチ・インスティテュート | 修飾された治療剤、及びその組成物 |
CN106456589B (zh) | 2013-12-18 | 2020-07-07 | 斯克利普斯研究所 | 修饰的治疗剂、订合的肽脂质缀合物及其组合物 |
MA41794A (fr) * | 2015-03-18 | 2018-01-23 | The California Institute For Biomedical Res | Agents thérapeutiques modifiés et compositions associées |
DK3387019T3 (da) | 2015-12-09 | 2022-01-10 | Scripps Research Inst | Relaxin-immunoglobulinfusionsproteiner og anvendelsesfremgangsmåder |
BR112019016139A2 (pt) | 2017-02-08 | 2020-04-07 | Bristol-Myers Squibb Company | polipeptídio de relaxina modificada compreendendo um melhorador farmacocinético e usos do mesmo |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0287820B1 (de) * | 1982-08-12 | 1992-07-08 | Howard Florey Institute Of Experimental Physiology And Medicine | Analoge des humanen Relaxins |
US4835251A (en) * | 1986-06-23 | 1989-05-30 | Genetech, Inc. | Method of chain combination |
US5478807A (en) * | 1991-08-19 | 1995-12-26 | Genentech, Inc. | Use of relaxin in the treatment of bradycardia |
US5166191A (en) * | 1991-08-19 | 1992-11-24 | Genentech, Inc. | Use of relaxin in cardiovascular therapy |
-
1995
- 1995-06-07 US US08/484,219 patent/US5911997A/en not_active Expired - Lifetime
-
1996
- 1996-05-16 WO PCT/US1996/007399 patent/WO1996040186A1/en active IP Right Grant
- 1996-05-16 AU AU58699/96A patent/AU709115B2/en not_active Expired
- 1996-05-16 AT AT96920364T patent/ATE229340T1/de active
- 1996-05-16 CA CA2224080A patent/CA2224080C/en not_active Expired - Lifetime
- 1996-05-16 EP EP96920364A patent/EP0831871B1/de not_active Expired - Lifetime
- 1996-05-16 JP JP50064897A patent/JP3830520B2/ja not_active Expired - Lifetime
- 1996-05-16 ES ES96920364T patent/ES2188763T3/es not_active Expired - Lifetime
- 1996-05-16 DE DE69625354T patent/DE69625354T2/de not_active Expired - Lifetime
-
2001
- 2001-04-30 US US09/846,149 patent/US6949506B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2224080A1 (en) | 1996-12-19 |
WO1996040186A1 (en) | 1996-12-19 |
AU5869996A (en) | 1996-12-30 |
US20030158376A1 (en) | 2003-08-21 |
DE69625354T2 (de) | 2003-10-30 |
EP0831871A1 (de) | 1998-04-01 |
DE69625354D1 (de) | 2003-01-23 |
ES2188763T3 (es) | 2003-07-01 |
US6949506B2 (en) | 2005-09-27 |
US5911997A (en) | 1999-06-15 |
JPH11512072A (ja) | 1999-10-19 |
JP3830520B2 (ja) | 2006-10-04 |
EP0831871A4 (de) | 1999-03-03 |
CA2224080C (en) | 2010-07-27 |
EP0831871B1 (de) | 2002-12-11 |
AU709115B2 (en) | 1999-08-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE229340T1 (de) | Relaxinartiger faktor und damit zusammenhängende verfahren und verwendungen | |
UA39099C2 (uk) | Циклічні азотовмісні похідні, суміш їх ізомерів або окремі ізомери, або їх солі | |
DE69315503D1 (de) | Aufblaseinrichtung für Gaskissen mit inhibierten, gaserzeugenden Zusammensetzungen | |
ES2195970T3 (es) | L-ribavirina y usos de la misma. | |
MX9203396A (es) | Monohidrato de furoato de mometasona, proceso para producirlo y composiciones farmaceuticas. | |
DE69216532T2 (de) | Azidfreie gaserzeugende Zusammensetzungen | |
NL1002835A1 (nl) | Synergistisch stabilisatormengsel. | |
HU9402342D0 (en) | Phosphono-oxymethyl-ethers of taxane derivatives | |
HUP9900936A1 (hu) | Izocianátalapú készítmények, bevonatként történő alkalmazásuk és az így előállított bevonatok | |
ATE221879T1 (de) | Kristalline paclitaxel hydrate | |
MX9804588A (es) | Uso de composiciones que comprenden blanqueador de halogeno para suavidad mejorada a la piel. | |
DE69421784T2 (de) | Kraftstoffzusammensetzungen, und Zusätze dafür | |
IL109720A (en) | N-alkylthio polyamine derivatives and radioprotective compositions containing them | |
ES2164684T3 (es) | Uso de antagonistas de taquiquininas en el tratamiento de emesis. | |
ES2134801T3 (es) | Monohidrato de hidrocloruro de tiagabina cristalina, su preparacion y su uso. | |
EA199800534A1 (ru) | ПРИМЕНЕНИЕ 2-ЭТИЛГЕКСИЛ-α-ЦИАНО-β, β-ДИФЕНИЛАКРИАТА ДЛЯ УЛУЧШЕНИЯ СТАБИЛЬНОСТИ КОСМЕТИЧЕСКИХ КОМПОЗИЦИЙ, СОДЕРЖАЩИХ П-МЕТИЛБЕНЗИЛИДЕНКАМФОРУВ СОЧЕТАНИИ С ДИБЕНЗОИЛМЕТАНОВЫМ ПРОИЗВОДНЫМ | |
HK1024164A1 (en) | Use of composition and a cosmetic method for reducing or preventing stinging | |
MX9602836A (es) | MEZCLA QUE CONTIENE UNO O VARIOS ALFA-AMINOACIDOS Y SUS DERIVADOS, O AMBOS, Y UNO O VARIOS CICLOPENTANO- beta-AMINOACIDOS Y SUS DERIVADOS, O AMBOS. | |
DE69407057D1 (de) | 1,3.5 (10) - estratriene derivate mit oraler wirkung | |
MX9603199A (es) | Antagonistas de receptores a endotelina. | |
EA200000531A1 (ru) | Применение кетолидов для профилактики тромботических артериальных осложнений, связанных с атеросклерозом | |
DK1189615T3 (da) | Endoparasiticid synergistisk kombination indeholdende cykliske depsipeptider og piperaziner | |
ES2115975T3 (es) | Derivados de triariletileno utilizados terapeuticamente. | |
DK0457127T3 (da) | Spermicidt belægningsmiddel | |
ATE204286T1 (de) | Modifizierte alpha-d-glcp-(1,2)-alpha-d-glcp-(1, 3)-alpha-d-glcp-analoge |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 0831871 Country of ref document: EP |